Sigma receptors and iboga alkaloids.

作者: Wayne D Bowen

DOI: 10.1016/S0099-9598(01)56013-7

关键词: IbogaineMuscarinic acetylcholine receptorDopaminePharmacologyAcetylcholineNeurotransmitterBiologyOpioidReceptorCalcium signaling

摘要: Publisher Summary Current evidence indicates that ibogaine and other iboga alkaloids might produce some of their neurotoxic effects by interaction with sigma-2 receptors. Sigma receptors are membrane proteins bind several psychotropic drugs high affinity. Two major subclasses sigma have been identified. These termed “sigma-1” “sigma-2,” they differentiated pharmacological profile, function, molecular size. Both subtypes to moderate affinity for typical neuroleptics, haloperidol exhibiting the highest both sites. The sigma-1 receptor has cloned in guinea pig, mouse, rat, human, shown be a novel protein > 90% species homology. Some functions attributed include following: (1) modulation synthesis release dopamine acetylcholine, (2) NMDA-type glutamatergic electrophysiology, (3) NMDA-stimulated neurotransmitter release, (4) muscarinic receptor-stimulated phosphoinositide turnover, (5) neuroprotective antiamnesic activity, (6) opioid analgesia, (7) alteration cocaine-induced locomotor activity toxicity. ability ligands induce morphological changes apoptosis led an investigation signaling mechanisms utilized

参考文章(70)
Robert H Mach, Cynthia R Smith, Isaf Al-Nabulsi, Brian R Whirrett, Steven R Childers, Kenneth T Wheeler, None, σ2 Receptors as Potential Biomarkers of Proliferation in Breast Cancer Cancer Research. ,vol. 57, pp. 156- 161 ,(1997)
P Popik, P Skolnick, R T Layer, 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacological Reviews. ,vol. 47, pp. 235- 253 ,(1995)
JB Michael, DB Martin, L Peter, Calcium - a life and death signal Nature. ,vol. 395, pp. 645- 648 ,(1998) , 10.1038/27094
R E Huppler, P E Gilbert, W R Martin, J A Thompson, C G Eades, The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. Journal of Pharmacology and Experimental Therapeutics. ,vol. 197, pp. 517- 532 ,(1976)
Bertold J. Vilner, Wayne D. Bowen, Modulation of Cellular Calcium by Sigma-2 Receptors: Release from Intracellular Stores in Human SK-N-SH Neuroblastoma Cells Journal of Pharmacology and Experimental Therapeutics. ,vol. 292, pp. 900- 911 ,(2000)
Bertold J. Vilner, Wayne D. Bowen, Christy S. John, Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines Cancer Research. ,vol. 55, pp. 408- 413 ,(1995)
G Debonnel, F P Monnet, C de Montigny, In vivo electrophysiological evidence for a selective modulation of N-methyl-D-aspartate-induced neuronal activation in rat CA3 dorsal hippocampus by sigma ligands. Journal of Pharmacology and Experimental Therapeutics. ,vol. 261, pp. 123- 130 ,(1992)
Michael King, Ying-Xian Pan, Jianfeng Mei, Albert Chang, Jin Xu, Gavril W Pasternak, Enhanced κ-opioid receptor-mediated analgesia by antisense targeting the σ1 receptor European Journal of Pharmacology. ,vol. 331, ,(1997) , 10.1016/S0014-2999(97)01064-9
Thuytien T. Tran, Brian R. de Costa, R. R. Matsumoto, Microinjection of sigma ligands into cranial nerve nuclei produces vacuous chewing in rats Psychopharmacology. ,vol. 137, pp. 191- 200 ,(1998) , 10.1007/S002130050609